1 / 10

Strategies for Enhancing Access to Medicines Some perspectives

Strategies for Enhancing Access to Medicines Some perspectives 1. Indicators 2. Interventions 3. Looking ahead. October 2001 Jonathan D. Quick, MD, MPH Essential Drugs and Medicines Policy (EDM) Health Technology and Pharmaceuticals Cluster World Health Organization. 1. Access indicators.

carver
Download Presentation

Strategies for Enhancing Access to Medicines Some perspectives

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Strategies for Enhancing Access to Medicines Some perspectives 1. Indicators 2. Interventions 3. Looking ahead October 2001 Jonathan D. Quick, MD, MPH Essential Drugs and Medicines Policy (EDM) Health Technology and Pharmaceuticals Cluster World Health Organization

  2. 1. Access indicators • Where are the variations? • Among sectors? Among countries? • Do findings confirm conventional wisdom? • Are indicators sufficiently robust? • Do interventions follow from findings?

  3. Country to country variations - do they suggest some local priorities?

  4. Country to country variations - do they suggest some local priorities?

  5. Do findings confirm conventional wisdom?Public sector less reliable?

  6. Do findings confirm conventional wisdom?Private sector more irrational?

  7. Do proposed interventions address affordability?

  8. Are indicators sufficiently robust to define problems and assess impact?

  9. 2. Interventions People are suffering and dying needlessly - medicines are unavailable, unaffordable, unsafe, or wrongly used • Policy context • human rights, equity, solidarity • financing, privatization, health reform • Household perspective • value for money - getting a better buy • price sensitivity - who is left out? • Economies of breadth - opportunities within country plans • safe dispensing, correct advice, appropriate referral • testing, prevention, treatment • expanded “customer base” for procurement systems • systems approach - linked interventions

  10. 3. Looking ahead • Colleagues are watching • creativity, innovation, impact • WHO committed • feedback, dissemination • Same time next year?

More Related